Skip to main content
. 2015 Oct 23;6:1186. doi: 10.3389/fmicb.2015.01186

Table 5.

E. cloacae STs identified in our study: clonal status, pulsotypes, centres, prevalence, carbapenem MIC and β-lactamases.

CC (ST)a PFGE profiles Centres Isolates (n) Median MIC (range; μg/mL)
β-lactamases (number of isolates)b,c
Imipenem Ertapenem Doripenem Meropenem
42 (101, 104, 108) 2,8,10,14,17–20 UH1, UH3, UH4, UH5, GH1, GH2 13 0.38 (0.13–1) 1 (0.75–4) 0.125 (0.047–0.75) 0.125 (0.064–0.5) SHV-12 (n = 1)
74 (74) 31–33,35,41 UH2, UH3, UH4, UH5, GH2, 16 0.62 (0.13–2) 2 (0.75–12) 0.25 (0.064–1) 0.44 (0.064–2) OXA-48 (n = 9), CTX-M-15 (n = 12)
114 (66,114) 3,5,40 UH1, UH3, UH5 7 0.38 (0.13–2) 2 (1–6) 0.125 (0.064–0.38) 0.19 (0.125–0.5) CTX-M-9 (n = 1) CTX-M-15 (n = 3), TEM-24 (n = 1), SHV-12 (n = 1)
133 (93, 103,133) 15,21,23,38,39 UH3, UH4, UH5, 10 0.44 (0.19–16) 2 (0.75–32) 0.125 (0.16–4) 0.16 (0.016–12) CTX-M-9 (n = 7), SHV-12 (n = 3)
234 (50,176,178) 24,34,37 UH2, UH3 3 0.5 (0.38–1) 2 (0.75–12) 0.25 (0.064–0.5) 0.38 (0.064–0.5) CTX-M-9 (n = 1), SHV-12 (n = 1)
ST110 28,29,30 UH1, UH4, GH2 8 0.38 (0.25–1) 1.25 (0.75–3) 0.125 (0.064–0.75) 0.16 (0.047–0.5) OXA-48 (n = 1), CTX-M-15 (n = 1), SHV-12 (n = 2)
ST179 ND,26,27 UH3, GH2 4 0.5 (0.5–0.75) 1 (0.75–4) 0.094 (0.064–0.38) 0.094 (0.064–0.75) OXA-48 (n = 1), CTX-M-15 (n = 1)
ST100 6,7 UH4 2 0.25 (0.25–0.25) 1.25 (1–1.5) 0.063 (0.032–0.094) 0.063 (0.032–0.094)
ST175 16 UH1, UH2 2 1.125 (0.25–2) 16.25 (0.75–32) 0.47 (0.19–0.75) 0.56 (0.125–1) SHV-12 (n = 1), DHA-1 (n = 1)
ST88,89, 102,173, 174,177, 180,181b 1,4,9,11–13, 25,36 UH1, UH4, UH5 10 0.25 (0.13–1) 0.88 (0.75–32) 0.1 (0.047–0.75) 0.079 (0.064–2) CTX-M-15 (n = 1), SHV-12 (n = 2), VIM-1 (n = 1)

aFor E. cloacae, clonal complex determined according to Izdebski et al. (2014).

bCarbapenemase, extended spectrum β-lactamase, plasmid-mediated cephalosporinase. TEM-1 and TEM-2 have not been mentioned.

cOne isolate in each ST.

ND, Not determined; NT, Non-typeable.